Structure Therapeutics Inc.
(GPCR - NASDAQ)
45,33 USD
📋 Profilo Aziendale

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.

|